NUPLAZID Trademark

Trademark Overview

On Tuesday, August 27, 2013, a trademark application was filed for NUPLAZID with the United States Patent and Trademark Office. The USPTO has given the NUPLAZID trademark a serial number of 86049322. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, April 4, 2023. This trademark is owned by ACADIA Pharmaceuticals Inc.. The NUPLAZID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
nuplazid

General Information

Serial Number86049322
Word MarkNUPLAZID
Filing DateTuesday, August 27, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, April 4, 2023
Registration Number5068987
Registration DateTuesday, October 25, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2014

Trademark Statements

Goods and ServicesPharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 5, 2013
Primary Code005
First Use Anywhere DateTuesday, May 31, 2016
First Use In Commerce DateTuesday, May 31, 2016

Trademark Owner History

Party NameACADIA Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameACADIA Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameACADIA Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, December 20, 2013NON-FINAL ACTION WRITTEN
Friday, August 30, 2013NEW APPLICATION ENTERED
Thursday, September 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 10, 2013ASSIGNED TO EXAMINER
Friday, December 20, 2013NON-FINAL ACTION E-MAILED
Friday, December 20, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 23, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 23, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 2, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 25, 2014ASSIGNED TO LIE
Monday, January 27, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2014PUBLISHED FOR OPPOSITION
Tuesday, March 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 26, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, August 26, 2014SOU EXTENSION 1 FILED
Wednesday, September 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 12, 2014SOU EXTENSION 1 GRANTED
Saturday, September 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 17, 2015SOU EXTENSION 2 FILED
Friday, April 17, 2015SOU TEAS EXTENSION RECEIVED
Friday, April 17, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 17, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 29, 2015SOU EXTENSION 2 GRANTED
Thursday, April 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 26, 2015SOU TEAS EXTENSION RECEIVED
Monday, October 26, 2015SOU EXTENSION 3 FILED
Thursday, October 29, 2015SOU EXTENSION 3 GRANTED
Friday, October 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 19, 2016SOU TEAS EXTENSION RECEIVED
Friday, February 19, 2016SOU EXTENSION 4 FILED
Thursday, March 3, 2016SOU EXTENSION 4 GRANTED
Friday, March 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 19, 2016TEAS STATEMENT OF USE RECEIVED
Friday, August 19, 2016SOU TEAS EXTENSION RECEIVED
Friday, August 19, 2016SOU EXTENSION 5 FILED
Friday, August 19, 2016USE AMENDMENT FILED
Wednesday, August 31, 2016SOU EXTENSION 5 GRANTED
Wednesday, August 31, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 19, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 20, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 25, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, April 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 25, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 23, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, April 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 4, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 4, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

nuplazid psychologic psychiatric diseases disorders genetic metabolic preparations prevention treatment neurologic